Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127432541 | 12743254 | 1 | I | 20070918 | 20160914 | 20160914 | EXP | US-ASTRAZENECA-2016SE97145 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160914 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127432541 | 12743254 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 60.0MG ONCE/SINGLE ADMINISTRATION | 0 | 60 | MG | INJECTION | |||||||
127432541 | 12743254 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 80.0MG ONCE/SINGLE ADMINISTRATION | 0 | 80 | MG | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127432541 | 12743254 | 1 | Antiviral prophylaxis |
127432541 | 12743254 | 2 | Antiviral prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127432541 | 12743254 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127432541 | 12743254 | Pneumonia viral | |
127432541 | 12743254 | Respiratory syncytial virus infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127432541 | 12743254 | 1 | 20061130 | 20061130 | 0 | |
127432541 | 12743254 | 2 | 20070219 | 20070219 | 0 |